Hypereosinophilic syndrome is a rare group of disorders that occurs when a particular type of white blood cell becomes dangerously elevated in the body, potentially leading to serious organ damage if left undiagnosed and untreated.

Introduction: Who Should Seek Diagnostics

Anyone experiencing persistent symptoms that don’t improve with typical treatments should consider seeking medical evaluation for hypereosinophilic syndrome. This is especially important if you have a combination of unexplained symptoms affecting different parts of your body at the same time. The disease can affect people at any age, though it’s most commonly diagnosed in adults between 20 and 50 years old, with some variants being more frequent in males.^[1]

You should talk to your healthcare provider if you notice symptoms like a rash that won’t go away, ongoing fatigue, persistent cough, shortness of breath, or unexplained fever that lasts for weeks. Other warning signs include belly pain with nausea and diarrhea, chest pain, dizziness, confusion, or numbness and tingling in parts of your body.^[2] Because these symptoms can also appear in many other conditions, it’s important not to ignore them, especially if they continue despite initial treatment attempts.

Early diagnosis is crucial because hypereosinophilic syndrome can be life-threatening if not treated promptly. The excess white blood cells called eosinophils—cells that normally help your body fight infections and respond to allergens—can infiltrate your organs and cause lasting damage. The heart is particularly vulnerable, and untreated cases can lead to heart failure, which is the leading cause of death in people with this syndrome.^[3]

Diagnostic Methods to Identify the Disease

Diagnosing hypereosinophilic syndrome is a process of elimination that requires multiple steps and various tests. Healthcare providers must first confirm that eosinophil levels are abnormally high, then determine whether organs are being damaged, and finally rule out all other possible causes of elevated eosinophils.^[4] This thorough approach ensures that patients receive the correct diagnosis and appropriate treatment.

Blood Tests and Eosinophil Counts

The foundation of diagnosis begins with a simple blood test called a complete blood count, which measures all types of blood cells including eosinophils. In healthy people, eosinophil levels typically range from 100 to 500 cells per microliter of blood. With hypereosinophilic syndrome, these levels climb to 1,500 or more per microliter.^[3] However, a single high reading isn’t enough for diagnosis. Your doctor will need to see elevated eosinophil counts on at least two separate occasions, typically more than one month apart, to confirm that the elevation is persistent rather than temporary.^[1]

Additional blood tests help paint a fuller picture of what’s happening in your body. These include tests to check liver and kidney function, as well as measurements of specific substances like vitamin B12, tryptase, and serum markers that can indicate certain variants of the syndrome. Elevated vitamin B12 and tryptase levels, for example, may suggest a myeloproliferative variant—a form where the bone marrow itself is producing too many eosinophils.^[4]

Ruling Out Other Causes

Before confirming hypereosinophilic syndrome, doctors must systematically exclude other conditions that can cause elevated eosinophils. This is a critical step because high eosinophil counts can result from many different causes, and the term hypereosinophilic syndrome is only used when no other explanation can be found.^[6]

Parasitic infections are among the most common causes of elevated eosinophils worldwide, so stool tests are routinely performed to detect parasites like hookworm or other intestinal organisms. Your doctor will ask detailed questions about travel history, exposure to contaminated water or food, and contact with animals.^[5]

Allergic diseases including asthma, food allergies, and environmental allergies can also elevate eosinophil counts. Allergy testing—which may include skin prick tests or blood tests for specific antibodies—helps determine whether allergies are driving the elevated cell counts. Similarly, autoimmune conditions, certain cancers, drug reactions, and infections must all be investigated and ruled out through appropriate testing.^[10]

Bone Marrow Examination

A bone marrow biopsy is recommended for most patients suspected of having hypereosinophilic syndrome. This procedure involves removing a small sample of bone marrow, usually from the hip bone, to examine under a microscope. The test reveals whether eosinophils make up more than 20% of all cells in the bone marrow, which indicates excessive production.^[1] More importantly, bone marrow examination can detect abnormalities suggesting that the syndrome originates from a problem within the bone marrow itself—what doctors call a primary or clonal disorder.

The bone marrow sample also undergoes genetic and molecular testing to look for specific chromosomal changes or gene mutations. One particularly important mutation involves a fusion of two genes called FIP1L1 and PDGFRA, which creates an abnormal protein with tyrosine kinase activity—an enzyme activity that transforms blood-forming cells. Identifying this mutation is crucial because patients with this variant respond exceptionally well to a specific medication called imatinib.^[4]

Assessing Organ Damage

Once persistent high eosinophil levels are confirmed, the next step is determining whether organs have been affected. Evidence of organ damage is essential for a hypereosinophilic syndrome diagnosis, as high eosinophil counts alone without tissue damage might simply be classified as hypereosinophilia rather than the full syndrome.^[6]

A chest X-ray and echocardiogram are routinely performed to evaluate the heart and lungs, since these are among the most commonly affected organs. An echocardiogram uses sound waves to create moving pictures of the heart, allowing doctors to see whether the heart muscle or valves have been damaged by infiltrating eosinophils. This test is particularly important because heart involvement can lead to life-threatening complications like heart failure.^[5]

Imaging tests such as computed tomography (CT) scans may be ordered to examine other organs that might be affected, depending on your symptoms. Lung function tests measure how well you can breathe in and out, helping detect any respiratory impairment. If nervous system symptoms are present, imaging of the brain or spinal cord may be necessary.^[10]

When specific organs appear damaged, tissue biopsies may be taken. A biopsy involves removing a tiny piece of tissue from the affected organ—such as skin, lung, or digestive tract—and examining it under a microscope. Pathologists look for extensive infiltration by eosinophils or deposits of proteins released by these cells, which cause the actual tissue damage.^[1]

Specialized Testing to Classify Variants

Modern diagnostic approaches aim to classify hypereosinophilic syndrome into specific variants, as this helps guide treatment decisions. Beyond the FIP1L1-PDGFRA fusion gene testing mentioned earlier, additional genetic and molecular studies may be performed on blood or bone marrow samples.^[9]

For the lymphocytic variant of hypereosinophilic syndrome, specialized blood tests examine T cells—another type of white blood cell. In this variant, abnormal T cells produce excessive amounts of a signaling protein called interleukin-5 (IL-5), which tells the body to make more eosinophils. Tests can detect these abnormal T cells through a technique called flow cytometry, which analyzes cell surface markers, and through molecular tests that reveal clonal T cell populations.^[4]

Other genetic tests look for different chromosomal rearrangements involving genes like PDGFRB, FGFR1, or JAK2. Each of these mutations creates a distinct form of the syndrome that may respond differently to treatment. Some patients may have chronic eosinophilic leukemia, where increased immature cells called blasts are found in the bone marrow but make up less than 20% of cells. These distinctions matter because they affect prognosis and treatment choices.^[4]

Diagnostics for Clinical Trial Qualification

When considering participation in clinical trials, patients with hypereosinophilic syndrome typically undergo a standardized set of tests to determine eligibility. Clinical trials use specific criteria to ensure that enrolled patients have confirmed diagnoses and that researchers can accurately measure how well experimental treatments work.^[11]

Baseline Eosinophil Measurements

Clinical trials generally require documented evidence of persistent eosinophilia, meaning blood eosinophil counts of 1,500 or more per microliter confirmed on multiple occasions. The time interval between measurements varies by study but often follows the traditional diagnostic criterion of at least one month apart. Some trials may require even longer documentation of elevated counts—sometimes up to six months—to ensure that participants truly have the chronic form of the disease rather than a temporary elevation.^[6]

Confirmation of Organ Involvement

Most clinical trials require objective evidence that hypereosinophilia has caused organ damage or dysfunction. This ensures that the trial is studying patients who might benefit from new treatments aimed at preventing further damage. Documentation typically includes results from echocardiograms showing heart involvement, imaging studies revealing lung or other organ changes, or biopsy results confirming eosinophil infiltration of tissues.^[11]

Some trials focus on specific organ involvement—for example, testing treatments specifically for heart complications of hypereosinophilic syndrome. In such cases, detailed cardiac testing including advanced imaging may be required. Blood tests measuring cardiac biomarkers like troponin, which indicates heart muscle damage, might also be used as screening tools.^[12]

Genetic and Molecular Characterization

Many modern clinical trials stratify patients based on genetic and molecular features. Trials testing tyrosine kinase inhibitors like imatinib typically require confirmation of specific genetic mutations through molecular testing. Tests for the FIP1L1-PDGFRA fusion gene are standard, using techniques like fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR) on blood or bone marrow samples.^[9]

Conversely, some trials specifically enroll patients without these mutations to test treatments for cases that don’t respond to currently available targeted therapies. These studies might require documentation that standard genetic testing was performed and returned negative results. Additional testing might examine whether patients have the lymphocytic variant with abnormal T cell populations, as this can affect trial eligibility and treatment approaches.^[11]

Exclusion of Secondary Causes

Clinical trials strictly require that other causes of elevated eosinophils have been thoroughly investigated and ruled out. This typically involves documentation of negative stool examinations for parasites, sometimes requiring multiple samples. Allergy testing results may need to be provided to confirm that allergic disease alone doesn’t explain the eosinophilia. Records showing that cancer screening has been performed and was negative may also be necessary.^[10]

Trials may exclude patients with certain conditions even if those conditions aren’t causing the eosinophilia. For example, active infections, uncontrolled autoimmune diseases, or recent treatment with certain medications that affect immune function might disqualify potential participants. These exclusions help ensure patient safety and prevent other conditions from interfering with interpretation of trial results.

Baseline Organ Function Assessment

Before enrolling in clinical trials, patients undergo comprehensive testing to establish baseline organ function. This typically includes blood tests to measure liver enzymes, kidney function markers, and blood cell counts beyond just eosinophils. These baseline measurements are crucial because they provide comparison points to detect any changes—positive or negative—that occur during the trial.^[10]

Pulmonary function tests measuring lung capacity and function are often required, especially if the investigational treatment might affect breathing or if lung involvement is part of the syndrome. Similarly, detailed heart function testing including electrocardiograms and echocardiograms establishes cardiac health status before treatment begins. Some trials monitoring novel treatments may require even more sophisticated testing like cardiac magnetic resonance imaging (MRI) to precisely measure heart function changes over time.

Previous Treatment History

Many clinical trials have specific requirements regarding previous treatments. Some trials only accept patients who haven’t responded to standard therapies, requiring documentation of failed treatment attempts with corticosteroids or other conventional medications. Others might exclude patients who’ve recently taken certain drugs because those medications could interfere with the experimental treatment being tested.^[12]

Documentation of treatment history typically includes records showing medication names, doses, duration of treatment, and response or lack of response to each therapy. This information helps researchers understand whether the new treatment offers benefits beyond what’s already available and ensures that study results can be properly interpreted.